Question 3: Logical Deduction of Epigenetic Tool Use Scenario: A hematologic malignancy is driven by the over-expression of the c-MYC oncogene. You are comparing two therapeutic strategies: using a BET inhibitor (an epigenetic reader tool) versus an EZH2 inhibitor (an epigenetic writer tool). Task: Based on their molecular mechanisms, deduce which tool would be more effective for immediate suppression of the MYC protein and explain why. Conversely, describe what would happen to the chromatin landscape if you used the writer inhibitor (EZH2i) on a system with H3K27me3-mediated repression.

Which would be more effective for immediate suppression of MYC protein: a BET inhibitor or an EZH2 inhibitor?

A BET inhibitor.

What do BET proteins (like BRD4) do?

They are epigenetic "readers" that bind to hyperacetylated regions of chromatin and actively promote gene transcription.

How do BET inhibitors (like JQ1) work?

They prevent BRD4 from binding to chromatin, immediately blocking RNA Polymerase II-mediated transcriptional elongation.

What happens to MYC transcription when BET is inhibited?

Rapid downregulation of MYC transcription and genome-wide reduction of Myc-dependent target genes.

What does EZH2 do?

It is an epigenetic "writer" that deposits the H3K27me3 repressive mark.

Why would an EZH2 inhibitor be ineffective for immediately suppressing MYC?

Because inhibiting a repressive writer typically leads to gene de-repression (activation), not suppression. It is logically inconsistent for silencing an over-expressed oncogene.

What is EZH2?

The catalytic subunit of the Polycomb Repressive Complex 2 (PRC2).

What happens to H3K27me3 levels when EZH2 is inhibited?

Global reduction in H3K27me3 levels.

What is the consequence of losing H3K27me3 marks?

Loss of the docking site for PRC1, preventing PRC1 from ubiquitinating histone H2A (which normally blocks RNA Polymerase II elongation).

What is the logical outcome of EZH2 inhibition on gene expression?

Reactivation (de-repression) of previously silenced genes.

How does the chromatin landscape change after EZH2 inhibition?

It transitions from a condensed, repressed state to an open state that allows transcriptional machinery access to promoters.

In what context can EZH2 inhibitors restore differentiation?

In systems like mutant IDH where H3K27me3 buildup contributes to a differentiation block, removing these repressive marks can restore the cell's capacity to respond to differentiation cu